{"id":51255,"date":"2021-10-05T08:04:24","date_gmt":"2021-10-05T06:04:24","guid":{"rendered":"https:\/\/smarthealth.live\/?p=51255"},"modified":"2021-10-04T15:07:12","modified_gmt":"2021-10-04T13:07:12","slug":"la-femtech-se-developpe-mais-reste-peu-performante","status":"publish","type":"post","link":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/","title":{"rendered":"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e"},"content":{"rendered":"

Le dernier rapport de Rock Health<\/a> dresse une analyse compl\u00e8te du paysage actuel de la Femtech. Et d\u2019apr\u00e8s leurs conclusions, le march\u00e9 est en pleine expansion. Depuis le d\u00e9but de l\u2019ann\u00e9e, les entreprises Femtech ont lev\u00e9 1,3 milliard de dollars. Il s'agit du plus gros montant de financement jamais atteint dans cette niche du march\u00e9 des soins de sant\u00e9. Cela repr\u00e9sente presque une hausse de plus de 50 % des investissements sur l'ensemble de l'ann\u00e9e 2020. N\u00e9anmoins, ce n'est que 7 % des investissements total dans les soins num\u00e9riques.<\/strong><\/p>\n

Selon le dernier rapport de Rock Health, les opportunit\u00e9s sont vastes dans les sous-domaines du march\u00e9 de la Femtech<\/a>. Pour autant, les jeunes entreprises se concentrent sur le d\u00e9veloppement de soins num\u00e9riques sp\u00e9cifiques. Les deux principales th\u00e9matiques trait\u00e9es sont la maternit\u00e9 (grossesse et la p\u00e9riode post-partum, soit avant et apr\u00e8s l\u2019accouchement) et la parentalit\u00e9. Un choix discutable puisque moins de 45 % des femmes am\u00e9ricaines sont en \u00e2ge d\u2019enfanter. En outre, le taux de natalit\u00e9 aux \u00c9tats-Unis n'a jamais \u00e9t\u00e9 aussi bas. Ainsi, \u00e0 en croire l\u2019analyse, une majorit\u00e9 de femmes ne se sent pas attirer par l'offre actuelle d'applications Femtech.<\/p>\n

Un secteur sous exploit\u00e9<\/h3>\n

Rock Health constate que l'\u00e9cosyst\u00e8me de la sant\u00e9 num\u00e9rique \u00e9volue rapidement. Il note d\u2019ailleurs une acc\u00e9l\u00e9ration des investissements depuis la crise sanitaire. N\u00e9anmoins, le cabinet d'\u00e9tudes affirme que les investisseurs et les fondateurs de la sant\u00e9 num\u00e9rique ne mesurent pas l\u2019immense potentiel de la Femtech. Pour eux, il est \u00e9vident qu\u2019un certain nombre de secteurs sont sous-expos\u00e9s. Le rapport souligne qu\u2019il existe tr\u00e8s peu de choses disponibles sp\u00e9cifiquement pour les personnes transgenres. Un oubli regrettable, d\u2019autant plus qu\u2019elles b\u00e9n\u00e9ficient d\u00e9j\u00e0 d'applications num\u00e9riques de soins primaires et chroniques. Rock Health pr\u00e9f\u00e8re donc parler de women+health plut\u00f4t que de Femtech. Une fa\u00e7on d\u2019inclure les start-ups qui travaillent pour ce groupe de personnes, y compris celles non binaires.<\/p>\n

Rock Health tire tout de m\u00eame la sonnette d\u2019alarme pour \u00e9viter que l'in\u00e9galit\u00e9 au sein des soins de sant\u00e9 continue de s'accro\u00eetre. Il faut que tous les utilisateurs soient \u00e9galement repr\u00e9sent\u00e9s dans la recherche clinique. Le rapport souligne \u00e9galement que la th\u00e9rapeutique num\u00e9rique (DTx), les avortements, les fausses couches, les mastectomies et les hyst\u00e9rectomies (ablation de l'ut\u00e9rus) sont des domaines qui m\u00e9ritent une plus grande attention au sein du march\u00e9 de la Femtech.<\/p>\n

Un tournant se pr\u00e9pare ?<\/h3>\n

Malgr\u00e9 tout, le march\u00e9 semble \u00e9voluer. En 2021, la Femtech a \u00e9t\u00e9 domin\u00e9e par les jeunes entreprises ax\u00e9es sur les soins primaires et pr\u00e9ventifs. L\u2019investissement est estim\u00e9 \u00e0 plus de 668 millions de dollars en capital. Maven Clinic et Tia sont les deux start-ups ayant re\u00e7u les montants les plus importants, avec respectivement 110 et 100 millions de dollars. Celles ax\u00e9es sur la fertilit\u00e9 ont lev\u00e9 330 millions de dollars. Quant aux projets num\u00e9riques sur la maternit\u00e9 ou la parentalit\u00e9, ils ont d\u00fb se contenter de \u00ab seulement \u00bb 316 millions de dollars. Autre fait marquant : l\u2019explosion des financements des start-ups abordant les soins de la m\u00e9nopause. En seulement deux ans, ils ont tout simplement doubl\u00e9 !<\/p>\n

Un recours in\u00e9gal aux soins<\/h3>\n

Le besoin croissant de d\u00e9ploiement d'applications num\u00e9riques de soins de sant\u00e9 semble bien r\u00e9el, en particulier chez les femmes. Contrairement aux hommes, elles utilisent moins souvent les outils num\u00e9rique<\/a>s, tels que les trackers de sant\u00e9 et les objets connect\u00e9s. L'ann\u00e9e derni\u00e8re, elles n\u2019\u00e9taient que 36 % \u00e0 avoir utilis\u00e9 un wearable contre 50 % pour les hommes.<\/p>\n

Rock Health indique qu'au cours des dix derni\u00e8res ann\u00e9es, seuls 5 % de tous les investissements dans les soins num\u00e9riques ont \u00e9t\u00e9 consacr\u00e9s aux Femtech. Aux \u00c9tats-Unis, les femmes ont davantage recours aux soins de sant\u00e9 que les hommes. Cette tendance s\u2019explique car elles n\u00e9cessitent de soins g\u00e9n\u00e9siques et prennent r\u00e9guli\u00e8rement des d\u00e9cisions pour leurs enfants. N\u00e9anmoins durant la pand\u00e9mie, elles ont eu plut\u00f4t tendance \u00e0 davantage reporter leurs soins. Selon les statistiques, pr\u00e8s d'un quart des femmes a eu des probl\u00e8mes pour payer leurs factures m\u00e9dicales au cours de l'ann\u00e9e \u00e9coul\u00e9e, notamment \u00e0 cause de la crise sanitaire.<\/p>\n","protected":false},"excerpt":{"rendered":"

Le potentiel des Femtech est \u00e9norme, mais reste \u00e0 ce jour sous exploit\u00e9 et non repr\u00e9sentatif de l'ensemble des groupes cibles.<\/p>\n","protected":false},"author":42,"featured_media":51240,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4649],"tags":[5070,5215,4709,4905,5217,5219,4882,5216,5218],"class_list":["post-51255","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-femtech-fr","tag-applications","tag-femmes","tag-femtech-fr","tag-financement","tag-maven-clinic","tag-rock-health-fr","tag-sante","tag-secteur-de-niche","tag-tia"],"acf":[],"yoast_head":"\nLa Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e - Smarthealth<\/title>\n<meta name=\"description\" content=\"Le potentiel des Femtech est \u00e9norme, mais reste \u00e0 ce jour sous exploit\u00e9 et non repr\u00e9sentatif de l'ensemble des groupes cibles.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e\" \/>\n<meta property=\"og:description\" content=\"Le potentiel des Femtech est \u00e9norme, mais reste \u00e0 ce jour sous exploit\u00e9 et non repr\u00e9sentatif de l'ensemble des groupes cibles.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/\" \/>\n<meta property=\"og:site_name\" content=\"Smarthealth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/smarthealthnl\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-05T06:04:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Vrouw.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1125\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sebas Eikholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartHealthNL\" \/>\n<meta name=\"twitter:site\" content=\"@SmartHealthNL\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sebas Eikholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/\"},\"author\":{\"name\":\"Sebas Eikholt\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/person\\\/0e4910a90a4d77ab7745f11e961ebf6b\"},\"headline\":\"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e\",\"datePublished\":\"2021-10-05T06:04:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/\"},\"wordCount\":760,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Vrouw.jpg\",\"keywords\":[\"applications\",\"femmes\",\"femtech\",\"financement\",\"Maven Clinic\",\"Rock Health\",\"sant\u00e9\",\"secteur de niche\",\"tia\"],\"articleSection\":[\"femtech\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/\",\"name\":\"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e - Smarthealth\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Vrouw.jpg\",\"datePublished\":\"2021-10-05T06:04:24+00:00\",\"description\":\"Le potentiel des Femtech est \u00e9norme, mais reste \u00e0 ce jour sous exploit\u00e9 et non repr\u00e9sentatif de l'ensemble des groupes cibles.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#primaryimage\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Vrouw.jpg\",\"contentUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Vrouw.jpg\",\"width\":2000,\"height\":1125,\"caption\":\"vrouw strand\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/2021\\\/10\\\/05\\\/la-femtech-se-developpe-mais-reste-peu-performante\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\",\"name\":\"Smarthealth\",\"description\":\"Het kennisplatform voor digital health\",\"publisher\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#organization\",\"name\":\"SmartHealth\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logofutura400PIXBREED.png\",\"contentUrl\":\"https:\\\/\\\/smarthealth.live\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logofutura400PIXBREED.png\",\"width\":400,\"height\":96,\"caption\":\"SmartHealth\"},\"image\":{\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/smarthealthnl\\\/\",\"https:\\\/\\\/x.com\\\/SmartHealthNL\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/#\\\/schema\\\/person\\\/0e4910a90a4d77ab7745f11e961ebf6b\",\"name\":\"Sebas Eikholt\",\"description\":\"Sebas werkt als redacteur bij SmartHealth. Hij heeft in 2012 de master Media Studies afgerond aan de Erasmus Universiteit Rotterdam. Hij is daarna o.a. werkzaam geweest bij Apple in Madrid, als freelance journalist en als redacteur bij het gezondheidsplatform Patient Empowerment.\",\"url\":\"https:\\\/\\\/smarthealth.live\\\/fr\\\/author\\\/sebas-eikholt\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e - Smarthealth","description":"Le potentiel des Femtech est \u00e9norme, mais reste \u00e0 ce jour sous exploit\u00e9 et non repr\u00e9sentatif de l'ensemble des groupes cibles.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/","og_locale":"fr_FR","og_type":"article","og_title":"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e","og_description":"Le potentiel des Femtech est \u00e9norme, mais reste \u00e0 ce jour sous exploit\u00e9 et non repr\u00e9sentatif de l'ensemble des groupes cibles.","og_url":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/","og_site_name":"Smarthealth","article_publisher":"https:\/\/www.facebook.com\/smarthealthnl\/","article_published_time":"2021-10-05T06:04:24+00:00","og_image":[{"width":2000,"height":1125,"url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Vrouw.jpg","type":"image\/jpeg"}],"author":"Sebas Eikholt","twitter_card":"summary_large_image","twitter_creator":"@SmartHealthNL","twitter_site":"@SmartHealthNL","twitter_misc":{"\u00c9crit par":"Sebas Eikholt","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#article","isPartOf":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/"},"author":{"name":"Sebas Eikholt","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/person\/0e4910a90a4d77ab7745f11e961ebf6b"},"headline":"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e","datePublished":"2021-10-05T06:04:24+00:00","mainEntityOfPage":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/"},"wordCount":760,"commentCount":0,"publisher":{"@id":"https:\/\/smarthealth.live\/fr\/#organization"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#primaryimage"},"thumbnailUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Vrouw.jpg","keywords":["applications","femmes","femtech","financement","Maven Clinic","Rock Health","sant\u00e9","secteur de niche","tia"],"articleSection":["femtech"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/","url":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/","name":"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e - Smarthealth","isPartOf":{"@id":"https:\/\/smarthealth.live\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#primaryimage"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#primaryimage"},"thumbnailUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Vrouw.jpg","datePublished":"2021-10-05T06:04:24+00:00","description":"Le potentiel des Femtech est \u00e9norme, mais reste \u00e0 ce jour sous exploit\u00e9 et non repr\u00e9sentatif de l'ensemble des groupes cibles.","breadcrumb":{"@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#primaryimage","url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Vrouw.jpg","contentUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2021\/10\/Vrouw.jpg","width":2000,"height":1125,"caption":"vrouw strand"},{"@type":"BreadcrumbList","@id":"https:\/\/smarthealth.live\/fr\/2021\/10\/05\/la-femtech-se-developpe-mais-reste-peu-performante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smarthealth.live\/fr\/"},{"@type":"ListItem","position":2,"name":"La Femtech se d\u00e9veloppe, mais reste sous exploit\u00e9e"}]},{"@type":"WebSite","@id":"https:\/\/smarthealth.live\/fr\/#website","url":"https:\/\/smarthealth.live\/fr\/","name":"Smarthealth","description":"Het kennisplatform voor digital health","publisher":{"@id":"https:\/\/smarthealth.live\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smarthealth.live\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/smarthealth.live\/fr\/#organization","name":"SmartHealth","url":"https:\/\/smarthealth.live\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/smarthealth.live\/wp-content\/uploads\/2013\/07\/logofutura400PIXBREED.png","contentUrl":"https:\/\/smarthealth.live\/wp-content\/uploads\/2013\/07\/logofutura400PIXBREED.png","width":400,"height":96,"caption":"SmartHealth"},"image":{"@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/smarthealthnl\/","https:\/\/x.com\/SmartHealthNL"]},{"@type":"Person","@id":"https:\/\/smarthealth.live\/fr\/#\/schema\/person\/0e4910a90a4d77ab7745f11e961ebf6b","name":"Sebas Eikholt","description":"Sebas werkt als redacteur bij SmartHealth. Hij heeft in 2012 de master Media Studies afgerond aan de Erasmus Universiteit Rotterdam. Hij is daarna o.a. werkzaam geweest bij Apple in Madrid, als freelance journalist en als redacteur bij het gezondheidsplatform Patient Empowerment.","url":"https:\/\/smarthealth.live\/fr\/author\/sebas-eikholt\/"}]}},"_links":{"self":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/51255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/comments?post=51255"}],"version-history":[{"count":6,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/51255\/revisions"}],"predecessor-version":[{"id":51257,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/posts\/51255\/revisions\/51257"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/media\/51240"}],"wp:attachment":[{"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/media?parent=51255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/categories?post=51255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smarthealth.live\/fr\/wp-json\/wp\/v2\/tags?post=51255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}